Introduction: A 52-Year-Old Woman with Intermediate-Risk Primary Myelofibrosis

Srdan Verstovsek, MD, PhD, comments on the patient profile and discusses the typical presentation of patients with myelofibrosis (MF).

Related Videos
John Allan, MD, an expert on chronic lymphocytic leukemia